Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Oxygen 1件: Oxygen3件: Medical air; Nitrogen; Oxygen; --20件: 6, 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 168, 193, 226, 271, 294, 299, 330
2 Oxiglutatione 1件: Glutathione2件: Glutathione; Reduced Glutathione; --2件: 6, 299
3 Orotic acid -0件: ---
4 Oxytocin 1件: Oxytocin2件: Oxytocin; Syntocinon; 1件: OXTR 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬6件: 6, 72, 127, 193, 206, 226
5 Oxytetracycline -0件: ---
6 Octreotide 1件: Octreotide3件: OCTREOTIDE; OCTREOTIDE ACETATE; Sandostatin LAR; 1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬7件: 67, 75, 84, 85, 89, 193, 227
7 Ofloxacin -0件: ---
8 Olanzapine 1件: Olanzapine2件: OLANZAPINE; Zyprexa; 11件: ADRA1A,
ADRA1B,
ADRA1D,
DRD2,
DRD3,
DRD4,
HRH1,
HTR2A,
HTR2B,
HTR2C,
HTR6 💬		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 2, 8
9 Omeprazole 1件: Omeprazole5件: Losec; Omeprazol; Omeprazole; Omeprazole 20 mg; OMEPRAZOLE MAGNESIUM; 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬16件: 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299
10 Ondansetron 1件: Ondansetron1件: Ondansetron; 5件: HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬		2件: Serotonergic synapse, Taste transduction 💬4件: 6, 97, 107, 231
11 Oxamniquine -0件: ---
12 Oxandrolone 1件: Oxandrolone1件: Oxandrolone; 1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬2件: 211, 285
13 Oxaprozin -0件: ---
14 Oxazepam -0件: ---
15 Oxybutynin 1件: Oxybutynin1件: Oxybutynin; 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬3件: 6, 13, 53
16 Oxymetholone -0件: ---
17 Oxcarbazepine 1件: Oxcarbazepine2件: Oxcarbazepine; Trileptal; 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13
18 Ondansetron hydrochloride hydrate 1件: Ondansetron1件: Ondansetron; 5件: HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬		2件: Serotonergic synapse, Taste transduction 💬4件: 6, 97, 107, 231
19 Oxybutynin chloride 1件: Oxybutynin1件: Oxybutynin; 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬3件: 6, 13, 53
20 Olsalazine sodium 1件: Olsalazine1件: Olsalazine; --1件: 271
21 Orphenadrine citrate -0件: ---
22 Oxiconazole nitrate 1件: Oxiconazole1件: Oxiconazole; --1件: 160
23 Oseltamivir phosphate 1件: Oseltamivir1件: Oseltamivir; --2件: 97, 299
24 Oxacillin sodium -0件: ---
25 Oxyphencyclimine hydrochloride -0件: ---
26 Oxymetazoline hydrochloride -0件: ---
27 Oxabolone cipionate -0件: ---
28 Oxethazaine -0件: ---
29 Olopatadine hydrochloride -0件: ---
30 Olmesartan medoxomil -0件: ---
31 Omeprazole sodium 1件: Omeprazole5件: Losec; Omeprazol; Omeprazole; Omeprazole 20 mg; OMEPRAZOLE MAGNESIUM; 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬16件: 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299
32 Oxypertine -0件: ---
33 Oxazolam -0件: ---
34 Oxymetebanol -0件: ---
35 Osalmid -0件: ---
36 Oxytetracycline hydrochloride -0件: ---
37 Ozagrel hydrochloride hydrate -0件: ---
38 Oxatomide 1件: Oxatomide1件: Oxatomide; 1件: ALOX5 💬6件: Arachidonic acid metabolism, Fc epsilon RI signaling pathway, Metabolic pathways, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis 💬1件: 113
39 Oxaliplatin -0件: ---
40 Omapatrilat -0件: ---
41 Oxtriphylline 1件: Theophylline1件: Theophylline; 18件: ADORA1,
ADORA2A,
PDE10A,
PDE11A,
PDE1A,
PDE1B,
PDE1C,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE7A,
PDE7B,
PDE8A,
PDE8B 💬		24件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 236, 299
42 Oxolinic acid -0件: ---
43 Oleic acid 1件: Oleic Acid1件: Oleic Acid; --2件: 13, 299
44 Oxypurinol -0件: ---
45 Orphenadrine hydrochloride -0件: ---
46 Ocinaplon -0件: ---
47 Ocaperidone -0件: ---
48 Olive oil 1件: Olive oil1件: Olive Oil; --3件: 13, 49, 53
49 Opium -0件: ---
50 Oxycodone terephthalate 1件: Oxycodone3件: Oxycodone; OXYCODONE HYDROCHLORIDE; Oxycodone/Acetaminophen; 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬7件: 6, 13, 46, 70, 226, 231, 298
51 Orlistat -0件: ---
52 Ocrelizumab 1件: Ocrelizumab2件: Ocrelizumab; OCREVUS; 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬3件: 13, 46, 49
53 Ocrylate -0件: ---
54 Octanoic acid -0件: ---
55 Octinoxate -0件: ---
56 Octisalate -0件: ---
57 Octocrylene -0件: ---
58 Octyldodecanol -0件: ---
59 Olaflur -0件: ---
60 Olmesartan -0件: ---
61 Omalizumab 1件: Omalizumab2件: Omalizumab; XOLAIR; 1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬7件: 46, 53, 65, 98, 162, 226, 299
62 Omega-3-acid ethyl esters -0件: ---
63 Omeprazole magnesium 1件: Omeprazole5件: Losec; Omeprazol; Omeprazole; Omeprazole 20 mg; OMEPRAZOLE MAGNESIUM; 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬16件: 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299
64 Omeprazole sodium injection 1件: Omeprazole5件: Losec; Omeprazol; Omeprazole; Omeprazole 20 mg; OMEPRAZOLE MAGNESIUM; 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬16件: 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299
65 Onercept -0件: ---
66 Opebacan -0件: ---
67 Oprelvekin 1件: Oprelvekin5件: IL-11; Interleukin 11; Interleukin-11; Oprelvekin; Recombinant interleukin-11; 1件: IL11RA 💬3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬2件: 96, 288
68 Oregovomab -0件: ---
69 Ornidazole -0件: ---
70 Oxfendazole -0件: ---
71 Oxfenicine -0件: ---
72 Oxibendazole -0件: ---
73 Oxidronic acid -0件: ---
74 Oxybenzone -0件: ---
75 Oxycodone 1件: Oxycodone3件: OXYCODONE; OXYCODONE HYDROCHLORIDE; Oxycodone/Acetaminophen; 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬7件: 6, 13, 46, 70, 226, 231, 298
76 Oxyphenbutazone hydrate -0件: ---
77 Oxyphenisatin acetate -0件: ---
78 Oxyquinoline 1件: Oxyquinoline1件: Oxine; --1件: 13
79 Oxytetracycline calcium -0件: ---
80 Oxycodone hydrochloride hydrate 1件: Oxycodone3件: OXYCODONE; OXYCODONE HYDROCHLORIDE; Oxycodone/Acetaminophen; 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬7件: 6, 13, 46, 70, 226, 231, 298
81 Octreotide acetate 1件: Octreotide3件: Octreotide; OCTREOTIDE ACETATE; Sandostatin LAR; 1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬7件: 67, 75, 84, 85, 89, 193, 227
82 Olanzapine pamoate 1件: Olanzapine2件: Olanzapine; Zyprexa; 11件: ADRA1A,
ADRA1B,
ADRA1D,
DRD2,
DRD3,
DRD4,
HRH1,
HTR2A,
HTR2B,
HTR2C,
HTR6 💬		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 2, 8
83 Oxyphenonium bromide -0件: ---
84 Oxaceprol -0件: ---
85 Ornipressin -0件: ---
86 Oxametacin -0件: ---
87 Oxycinchophen -0件: ---
88 Oxitriptan -0件: ---
89 Oxaflozane -0件: ---
90 Oxiracetam -0件: ---
91 Oxolamine -0件: ---
92 Oxomemazine -0件: ---
93 O-Acetyldihydrocodeine hydrochloride -0件: ---
94 Octenidine -0件: ---
95 Oblimersen -0件: ---
96 Olopatadine -0件: ---
97 Olsalazine 1件: Olsalazine1件: Olsalazine; --1件: 271
98 Omoconazole -0件: ---
99 Opipramol -0件: ---
100 Orbifloxacin -0件: ---
101 Orciprenaline -0件: ---
102 Ormeloxifene -0件: ---
103 Ornithine 1件: Ornithine1件: Ornithine; --2件: 245, 251
104 Orphenadrine -0件: ---
105 Oseltamivir 1件: Oseltamivir1件: Oseltamivir; --2件: 97, 299
106 Oxacillin -0件: ---
107 Oxeladin -0件: ---
108 Oxetorone -0件: ---
109 Oxiconazole 1件: Oxiconazole1件: Oxiconazole; --1件: 160
110 Oxilofrine -0件: ---
111 Oxprenolol -0件: ---
112 Oxybuprocaine 1件: Oxybuprocaine1件: Oxybuprocaine; 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6
113 Oxyfedrine -0件: ---
114 Oxymetazoline -0件: ---
115 Oxymorphone 1件: Oxymorphone1件: Opana; 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 70
116 Oxyphenbutazone -0件: ---
117 Oxyphencyclimine -0件: ---
118 Oxyphenisatine -0件: ---
119 Ozagrel -0件: ---
120 Odanacatib -0件: ---
121 Omacetaxine mepesuccinate -0件: ---
122 Ospemifene -0件: ---
123 Otelixizumab 1件: Otelixizumab1件: Otelixizumab; 3件: CD3D,
CD3E,
CD3G 💬		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 46
124 Ofatumumab 1件: Ofatumumab4件: Arzerra; HuMax-CD20; Kesimpta; OFATUMUMAB; 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬3件: 13, 35, 46
125 Obinutuzumab 1件: Obinutuzumab2件: GAZYVARO; OBINUTUZUMAB; 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 49, 222
126 Obeticholic acid 1件: Obeticholic acid4件: 6-ECDCA; 6-ethylchenodeoxycholic acid; Obeticholic Acid; Ocaliva; 1件: NR1H4 💬1件: Bile secretion 💬3件: 93, 265, 296
127 Otenabant -0件: ---
128 Ozenoxacin -0件: ---
129 Onapristone -0件: ---
130 Ocriplasmin -0件: ---
131 Omadacycline 1件: Omadacycline1件: Omadacycline; --1件: 299
132 Omecamtiv mecarbil -0件: ---
133 Orvepitant -0件: ---
134 Olaparib 1件: Olaparib1件: Olaparib; 2件: PARP1,
PARP2 💬		5件: Apoptosis, Base excision repair, Diabetic cardiomyopathy, NF-kappa B signaling pathway, Necroptosis 💬2件: 86, 285
135 Olaratumab -0件: ---
136 Onartuzumab -0件: ---
137 Oxelumab -0件: ---
138 Ozoralizumab 1件: Ozoralizumab1件: Ozoralizumab; 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
139 Ondelopran -0件: ---
140 Olodaterol -0件: ---
141 Orteronel -0件: ---
142 Omarigliptin -0件: ---
143 Oprozomib -0件: ---
144 Ozanezumab 1件: Ozanezumab1件: Ozanezumab; 1件: RTN4 💬1件: Alzheimer disease 💬1件: 2
145 Ombitasvir -0件: ---
146 Omipalisib -0件: ---
147 Onalespib -0件: ---
148 Obiltoxaximab -0件: ---
149 Olipudase alfa 1件: Olipudase alfa1件: Olipudase alfa; 1件: SMPD1 💬5件: Lysosome, Metabolic pathways, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬1件: 19
150 Opicapone 1件: Opicapone2件: Ongentys; OPICAPONE; 1件: COMT 💬4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6
151 Olmutinib -0件: ---
152 Ofranergene obadenovec -0件: ---
153 Oleclumab -0件: ---
154 Omaveloxolone 1件: Omaveloxolone1件: Omaveloxolone; 1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18
155 Omidenepag isopropyl -0件: ---
156 Ozanimod 1件: Ozanimod2件: Ozanimod; Zeposia; 5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 96, 97
157 Osilodrostat 1件: Osilodrostat1件: OSILODROSTAT; 1件: CYP11B2 💬3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75
158 Olumacostat glasaretil -0件: ---
159 Oliceridine -0件: ---
160 Olendalizumab -0件: ---
161 Otilimab 1件: Otilimab1件: Otilimab; 1件: CSF2 💬16件: Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬2件: 46, 256
162 Olacaftor -0件: ---
163 Oxycodegol -0件: ---
164 Olorinab -0件: ---
165 Onvansertib -0件: ---
166 Olinciguat -0件: ---
167 Obexelimab -0件: ---
168 Omburtamab -0件: ---
169 Odronextamab -0件: ---
170 Onasemnogene abeparvovec 1件: Onasemnogene abeparvovec3件: ONASEMNOGENE ABEPARVOVEC; Onasemnogene Abeparvovec-xioi; Zolgensma; 1件: SMN1 💬-1件: 3
171 Odevixibat 1件: Odevixibat1件: Odevixibat; 1件: SLC10A2 💬1件: Bile secretion 💬3件: 296, 297, 338
172 Opicinumab 1件: Opicinumab1件: Opicinumab; 1件: LINGO1 💬-1件: 13
173 Oteseconazole -0件: ---
174 Oportuzumab monatox -0件: ---
175 Odesivimab -0件: ---
176 Orilanolimab 1件: Orilanolimab1件: ORILANOLIMAB; 1件: FCGRT 💬-1件: 61
177 Orelabrutinib 1件: Orelabrutinib1件: Orelabrutinib; 1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬3件: 13, 61, 63